lifestyle.brownplanet.com

Author: Azenta, Inc.

Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029

May 5, 2026
Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast

April 29, 2026
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution

April 7, 2026
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities

March 13, 2026
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference

March 11, 2026
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure

March 9, 2026
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025

March 8, 2026
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast

January 21, 2026
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.

December 29, 2025
Azenta Authorizes $250 Million Share Repurchase Program

December 11, 2025